The DRC's new VP of Economic Development, Kelly Cloud, is spearheading efforts to attract startups and established life science companies to Dallas-Fort Worth.
MORE►
biotech
[Source Images: DRC, iStockphoto]
Dallas Regional Chamber Launches Life Science Recruitment Campaign
by Nicole Ward | Feb 22, 2023
The campaign builds on the region's thriving tech sector as the foundation of Dallas-Fort Worth's growing biotech and life science ecosystem. “What we’re seeing now is the cumulative effect of convergence across industries—and that gives DFW an edge," says Mike Rosa, the DRC's economic development chief.
The DRC's new VP of Economic Development, Kelly Cloud, is spearheading efforts to attract startups and established life science companies to Dallas-Fort Worth.
The DRC's new VP of Economic Development, Kelly Cloud, is spearheading efforts to attract startups and established life science companies to Dallas-Fort Worth.
by Sandra Engelland |
Feb 15, 2023
From AI to human longevity to xTech, North Texas experts George Brody of InfoNet of Things and Anurag Jain of Perot Jain, along with Mike Bechtel of Deloitte, predict a range of emerging technologies set to transform the world in 2023 and beyond.
MORE►
by Lance Murray |
Jan 11, 2023
Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.
Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products....
MORE►
by Lance Murray |
Dec 8, 2022
Southlake-based Renibus Therapeutics—a clinical-stage biotech company developing innovative products for cardiorenal diseases—has received $33 million in bridge financing to help it advance three drugs in its pipeline. The drugs are currently in various phases of trials.
MORE►
[Graphic: JLL]
JLL’s DFW Life Science Snapshot: What’s Driving the North Texas Biotech Boom
by Lance Murray | Oct 4, 2022
The North Texas biotech boom just keeps booming—and a new "DFW Life Science Snapshot" from JLL shows why. From the Biotech+ Hub at Pegasus Park to a string of accelerators to local universities, DFW Airport, and more, here's a deep dive into what's behind the boom.
"We are showing up in the rankings and in the data," says Mike Rosa of the Dallas Regional Chamber. "It results in more opportunities and more looks for us."
MORE►
by Kevin Cummings |
Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE►
by Lance Murray |
Aug 20, 2022
Brannon Morisoli will join the team at a time when life science is booming in North Texas. Most recently, Dallas-Fort Worth ranked for the first time in the "Top 20 U.S. metros for life science" 2022 report by CommercialEdge.
MORE►
by Sandra Engelland |
Aug 3, 2022
Top North Texas healthcare and life science employers—including UT Southwestern, McKesson, Evolve Biologics, Texas Health Resources, and more—have already signed up to hire 1,100 biotech workers from the groundbreaking program.
27,000 workers have made Dallas-Fort Worth a Top 20 U.S. metro for life sciences companies. As the boom continues, they’ll need company. Here's how the grant will help Dallas College and other local higher ed institutions step up to provide it—and why a CEO at Lyda Hill Philantrhopies calls it a "game changer."
27,000 workers have made Dallas-Fort Worth a Top 20 U.S. metro for life sciences companies. As the boom continues, they’ll need company. Here's how the grant will help Dallas College and other local higher ed institutions step up to provide it—and why a CEO at Lyda Hill Philantrhopies calls it a "game changer."
MORE►
Left to right: Dr. Shehnaaz Suliman, CEO and board member of ReCode; and David Lockhart, president and chief science officer. [Photos: Jennifer Leahy]
Dallas-Founded Biopharma Firm Raises $120M to Expand its Pipeline
by Kevin Cummings | Jun 29, 2022
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases.
With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
MORE►
by Dave Moore |
May 24, 2022
"It takes time" to establish a track record, Jorge Varela says, and the region is starting to see a series of biotech successes and spinoffs that will elevate the region's profile as a biotech hub.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
MORE►
![Southwestern Medical Foundation President and CEO Kathleen Gibson has joined the board of nonprofit LaunchBio. [Image: Southwestern Medical Foundation; istockphoto]](https://s24806.pcdn.co/wp-content/uploads/2022/04/Kathleen-Gibson-LaunchBio-board-360x203.jpg)
by Quincy Preston |
Apr 29, 2022
LaunchBio, a life science and biotech nonprofit that expanded to North Texas in 2021, has announced four new board members, including Dallas-based Kathleen Gibson, along with a new board chair.
LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
MORE►
by Kevin Cummings |
Apr 27, 2022
Through a three-year partnership called the North Texas Funders Initiative, The Dallas Foundation and local leadership impact nonprofit RevJen Group, along with others including Lyda Hill Philanthropies, will bring leadership development training to over 300 nonprofit leaders each year.
MORE►
Frank Stonebanks, CEO of Renibus Therapeutics. [Photo: Renibus]
With New Funding and CEO, This Southlake Biotech is Looking to Solve Kidney Disease
by Kevin Cummings | Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE►
by Dave Moore |
Dec 6, 2021
Mississauga, Ontario-based Evolve Biologics is a producer of plasma-derived therapeutics. The firm's CEO says the new, state-of-the-art, 200,000-SF Sachse facility "will be the foundation of our future growth and global strategy," with the capacity to process 1 million liters of plasma annually and a planned expansion to 2 million liters.
MORE►
Dallas-Based Vaxxinity Prepares for $100M IPO; Aims to Turn Immune Systems Into ‘Antibody Factories’
by David Seeley |
Nov 8, 2021
Vaxxinity's COVID-19 vaccine candidate is "super safe and mild and doesn’t bring recipients down for a couple of days with flu-like symptoms," says the company's co-founder and CEO, Mei Mei Hu. Unlike mRNA vaccines from Modern and Pfizer, Vaxxinity says its protein peptide-based platform is based on tech that led to a vaccine for foot-and-mouth disease in livestock.
MORE►
by Alex Edwards |
Oct 14, 2021
It's the San Franciso company's first office in Texas. Verily expects to hire as many as 115 employees by the end of 2022.
MORE►
